MetLife (NYSE:MET) Price Target Cut to $89.00 by Analysts at Barclays

MetLife (NYSE:MET) had its price objective lowered by Barclays from $92.00 to $89.00 in a report issued on Wednesday morning,Benzinga reports. The firm currently has an overweight rating on the financial services provider’s stock.

MET has been the topic of a number of other research reports. Mizuho set a $100.00 target price on MetLife in a report on Thursday, February 12th. Weiss Ratings lowered MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, March 9th. Morgan Stanley dropped their target price on MetLife from $101.00 to $93.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. TD Cowen dropped their target price on MetLife from $91.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, March 11th. Finally, Keefe, Bruyette & Woods restated a “moderate buy” rating and issued a $87.00 target price on shares of MetLife in a report on Thursday, March 26th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and an average price target of $93.33.

MetLife Stock Up 4.4%

Shares of NYSE:MET opened at $74.32 on Wednesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. The business’s 50 day simple moving average is $73.36 and its two-hundred day simple moving average is $77.06. The firm has a market cap of $48.46 billion, a P/E ratio of 15.81, a PEG ratio of 0.63 and a beta of 0.74. MetLife has a 52-week low of $66.83 and a 52-week high of $83.85.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $0.15. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The firm had revenue of $52.44 billion during the quarter, compared to analyst estimates of $31.43 billion. During the same period in the previous year, the company posted $2.08 EPS. The company’s revenue for the quarter was up 27.6% on a year-over-year basis. As a group, research analysts forecast that MetLife will post 9.65 EPS for the current fiscal year.

Institutional Trading of MetLife

A number of hedge funds have recently bought and sold shares of MET. Providence Capital Advisors LLC purchased a new stake in MetLife in the third quarter worth $6,649,000. Thrivent Financial for Lutherans increased its position in MetLife by 8.9% in the third quarter. Thrivent Financial for Lutherans now owns 1,176,469 shares of the financial services provider’s stock worth $96,905,000 after buying an additional 96,523 shares during the last quarter. Nordea Investment Management AB increased its position in MetLife by 2.6% in the fourth quarter. Nordea Investment Management AB now owns 4,630,165 shares of the financial services provider’s stock worth $366,524,000 after buying an additional 117,545 shares during the last quarter. Varma Mutual Pension Insurance Co increased its position in MetLife by 21.9% in the third quarter. Varma Mutual Pension Insurance Co now owns 137,956 shares of the financial services provider’s stock worth $11,363,000 after buying an additional 24,800 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its position in MetLife by 256.8% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 62,662 shares of the financial services provider’s stock worth $5,161,000 after buying an additional 45,100 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife reported preliminary, unaudited first-quarter variable investment income of at least $475 million, a figure investors view as a meaningful boost to Q1 earnings and reserves expectations. MetLife sees Q1 variable investment income of at least $475M
• Neutral Sentiment: Barclays lowered its price target to $89 from $92 but maintained an “overweight” rating, signaling continued analyst confidence and suggesting further upside potential despite the small cut. Benzinga: Barclays price target update
• Neutral Sentiment: MetLife set its first-quarter 2026 results release for May 6 (after the close) and will host a May 7 earnings call — an upcoming catalyst that can drive short-term volatility and re-rate the stock on reported results and supplements. MetLife to Announce First Quarter 2026 Results
• Neutral Sentiment: Local news about the 2026 FIFA World Cup at MetLife Stadium (Penn Station partial closures, fan festivals at American Dream Mall) boosts public visibility of the MetLife name but is unlikely to materially affect the insurer’s financials. Investors should view these as brand/PR items rather than earnings drivers. World Cup at MetLife Stadium will force Penn Station to partially close for 4 hours before matches, source says
• Neutral Sentiment: Additional World Cup event planning includes large fan festivals (e.g., American Dream Mall), reinforcing local consumer activity around the MetLife Stadium events but with limited direct impact on MetLife, Inc.’s core insurance operations. American Dream Mall to host massive 2026 World Cup fan festival

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.